Yang Liu

Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors

Zhenguang Wang, Na Li, Kaichao Feng et al. · Cellular and Molecular Immunology · 2021 · 257 citations · Full text

Life Sciences, Immunology, Oncology +17

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression

Yang Liu, Dawei Ma, Yuepeng Cao et al. · Theranostics · 2021 · 97 citations · Full text

Life Sciences, Genetics, Oncology +17

Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway

Xingxiang Liu, Wei Zhao, Wei Wang et al. · Biomedicine & Pharmacotherapy · 2017 · 96 citations

Life Sciences, Cell Biology, Oncology +9

Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis

Junchao Xue, Yang Liu, Fei Luo et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2017 · 81 citations

Life Sciences, Cell Biology, Molecular Biology +16

Immune Responsive Release of Tacrolimus to Overcome Organ Transplant Rejection

Jindao Wu, Zhen Zheng, Yuanyuan Chong et al. · Advanced Materials · 2018 · 80 citations

Pharmacy, Immunology, Pharmaceutics +16